GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Piramal Pharma Ltd
Piramal Pharma Ltd — Directorate Change Announced
MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 28 Apr 2026, 09:25 PM IST  ·  BSE ID: 17d5c49f-1241-4684-85ca-668043685051
View Original BSE Filing (PDF)
💡
In Simple Terms
Piramal Pharma's board of directors changed in April 2026, but the exact details are not accessible in the filing.
🤖 AI Summary
  • Piramal Pharma announced directorate change on 28 April 2026 via BSE filing
  • Filing references attached details but document is not publicly accessible
  • Change type — appointment, resignation, or other — not specified in available text
  • Disclosure made under SEBI Regulation 30 material event reporting requirement
  • Shareholders should request full details from company investor relations office
🏢 How This Affects the Company
⚙️
Operational Impact
Board composition has changed. Full impact on governance, decision-making authority, and operational oversight cannot be assessed without detailed disclosure of who joined or departed and their roles.
👥 What This Means For Shareholders
✅
Action Required
Request full directorate change details from Piramal Pharma investor relations or access the complete BSE filing attachment.
👤
Who Is Affected
All shareholders. Board changes affect corporate governance, decision-making, and risk oversight across the entire company.
🔍
Management Signal
Company is disclosing board changes as required by regulation, but incomplete public disclosure limits transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Request full directorate change details from company investor relations — obtain names and roles
Check updated board composition on company website and BSE filings portal for governance impact
Monitor Q1 FY27 results for any strategic shifts signaled by new board member appointments
MEDIUM RISK Board changes introduce governance uncertainty. Lack of accessible detail prevents assessment of experience, independence, or conflict-of-interest concerns.
💡 Investor Takeaway
Piramal Pharma disclosed a directorate change on 28 April 2026 under SEBI Regulation 30. The attached document containing specific details is not accessible. Shareholders should request full disclosure directly from the company to understand board composition changes, roles, and governance implications.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Filing references attached document which is not publicly accessible — full disclosure unclear to investors
  • Exact nature of directorate change — appointment, resignation, role assignment — not stated in available text
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.